System Chief of Academic Malignant Hematology

Northwell Health Physician Partners; Manhasset (NY); On-site; USD 300,000 - 500,000; Full time

Job summary

Northwell Health Physician Partners in Manhasset seeks a visionary System Chief of Hematologic Malignancies to lead hematologic oncology research programs. This role focuses on building a world-class clinical research program, fostering academic excellence, and steering a robust clinical trials infrastructure. Ideal candidates will hold an MD or MD/PhD, be board-certified, have significant expertise in hematologic malignancies, and a proven track record in cancer research. Join Northwell's mission to provide exceptional cancer care and expand access to innovative therapies.

Qualifications

• Significant clinical expertise and national/international reputation in hematologic malignancies.
• Demonstrated track record of productive clinical and translational cancer research.
• Active or eligible for medical licensure in New York State.

Responsibilities

• Design and implement a cohesive system-wide strategy for hematologic malignancies.
• Establish disease-specific centers of excellence.
• Drive a robust clinical trials infrastructure for hematologic malignancies.

Skills

Board Certification in Hematology and/or Medical Oncology

Clinical expertise in hematologic malignancies

Track record of cancer research

Successful in obtaining peer-reviewed funding

Medical licensure in New York State

Education

MD or MD/PhD from an accredited institution

Eligibility for appointment at the rank of Associate Professor or Professor

Job description

Northwell Health Cancer Institute | New York's Largest Health System

The Northwell Health Cancer Institute seeks a visionary physician leader to serve as the inaugural System Chief of Hematologic Malignancies. This landmark role is designed to advance and expand our hematologic oncology research programs across one of the nation's most dynamic health systems. This role aligns with the Institute's mission to break through geographic, socioeconomic, and access barriers, ensuring that people receive the state-of-the-art, compassionate cancer care with access to cutting-edge investigational therapies.

We seek a dynamic individual to build a world-class clinical and translational research program in hematologic malignancies. Northwell Health treats more than 24,000 patients with cancer annually and provides access to over 400 Cancer Institute physicians across more than 25 subspecialties. The Cancer Institute continues to set new standards in clinical care, research, and training across the New York metropolitan region. With the recent acquisition of Nuvance Health, our reach now extends into Connecticut and the Hudson Valley. This leader will be instrumental in shaping our strategic growth as a health system that provides access to research and clinical trials for oncology care.

The Feinstein Institute for Medical Research serves as the hub of Northwell Health's research enterprise and a center for scientific discovery and innovation, including the Institute of Cancer Research, where groundbreaking translational cancer research is performed. In addition, a strategic partnership established in 2015 between Northwell Health and Cold Spring Harbor Laboratory has accelerated the translation of basic science discoveries into patient care through the development of innovative early-phase clinical trials.

As System Chief of Hematologic Malignancies, you will have the following responsibilities:

Build a Premier Program

• Design and implement a cohesive system-wide strategy for hematologic malignancies
• Establish disease-specific centers of excellence with dedicated multidisciplinary teams for:
• Lymphoma (Hodgkin and Non-Hodgkin)
• Leukemia (Acute and Chronic - ALL, AML, CLL, CML)
• Multiple Myeloma and Plasma Cell Disorders
• Collaborate with our cellular therapy and bone marrow transplant programs to create a seamless continuum of care from diagnosis through survivorship
• Drive a Bold Research Agenda
• Establish and fortify a robust clinical trials infrastructure for hematologic malignancies, including early-phase (Phase I/II) investigator-initiated studies
• Recruit and mentor physician-scientists to build translational and clinical research portfolios
• Pursue NCI designation contributions through scholarly output, grant funding, and programmatic development

Focus on Academia

• Foster a culture of academic excellence
• Develop the next generation of leaders through medical education, fellowship training, and mentorship programs
• Partner with the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell to advance educational and academic missions

Qualifications

• MD or MD/PhD from an accredited institution
• Board Certification in Hematology and/or Medical Oncology
• Significant clinical expertise and national/international reputation in one or more areas of hematologic malignancies (lymphoma, leukemia, myeloma, MDS/MPNs)
• Demonstrated track record of productive clinical and translational cancer research
• Proven success in obtaining external peer-reviewed funding
• Eligibility for appointment at the rank of Associate Professor or Professor at the Zucker School of Medicine
• Active or eligible for medical licensure in New York State

Why Northwell Health?

Northwell Health is New York State's largest health care provider and private employer, with 28 hospitals and 1,050 outpatient facilities. Nuvance Health, which provides exceptional care for the Hudson Valley and western Connecticut communities, has proudly joined Northwell. This means expanded access to renowned care, resources and expertise has come to 12 counties. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 103,500 employees - 19,000+ nurses and 12,000+ credentialed physicians, including members of Northwell Health Physician Partners - are working to change health care for the better. Northwell's cancer enterprise is experiencing a period of unprecedented investment and growth.